|
|
| |
|
Matthew B. Gretzer,
MD
Assistant Professor of Clinical Surgery
Director of Urology/Surgery
UPH at Kino Campus
Arizona Health
Sciences Center
Department of Surgery
1501 N. Campbell Avenue, Rm.
4409
PO Box 245077
Tucson, AZ 85724-5077
Appointments: (520) 694-4032
Multi-Specialty Surgery Clinic at Kino Campus
2800 E. Ajo Way
Tucson, AZ 85713
Appointments: 874-2000
Office Phone: (520)
626-6236
Fax:
(520) 626-4933
Email: mgretzer@surgery.arizona.edu
|
.jpg)
|
| |
| Education |
|
MD:
|
1998, University of Texas Health Science Center, San Antonio, Texas |
|
Residencies:
|
1998-2000: General Surgery, Johns Hopkins Hospital/School of Medicine
|
|
|
2000-2004: Urology, Johns Hopkins Hospital/School of Medicine, James Buchanan Brady Urological Institute |
|
Fellowship
|
2004-2005: Johns Hopkins Hospital/James Buchanan Brady Urological Institute |
|
|
|
|
Clinical Specialties
General Urology, BPH, Prostate Cancer and Urologic Oncology, Pelvic Laparoscopy, Robotic Prostatectomy, Genito-Urinary Reconstruction
Board Certifications
American Board of Urology, 2007
Research
Urologic Oncology/Prostate Cancer Tumor Markers.
Investigator in a study evaluating a novel therapy for male incontinence.
Selected Publications
- Gretzer MB, Partin, AW, and Chan DY. Lower Urinary Tract Symptoms and BPH. Minimally Invasive Urologic Surgery. Eds: Moore, Bishoff, Loening, and Docimo. Chapter 25. 351-373. 2005
- Gretzer MB, Chan DW, van Rootselaar CL, Rosenzweig J, Dalrymple S, Mangold LA, Partin AW, and Veltri RW. Proteomic Analysis of Dunning Prostate Cancer Cell Lines with Variable Metastatic Potential Using SELDI-TOF. Prostate. 2004 Sep 1;60(4):325-31.
- Gretzer MB and Wright EJ. Use of Cadaveric Fascia Lata Allograft for Pubovaginal Slings. Vasavada et al. Female Urology, Urogynecology, and Voiding Dysfucnction. Chaper 23. 353-361. 2004.
- Gretzer MB, and Partin. AW. Molecular forms of PSA: What does the future hold? Antigen’s various molecular forms may improve PSA test’s clinical utility. Urology Times. October 2003. 42-43.
- Gretzer MB, and Partin AW. PSA and PSA molecular derivatives. Campbells Update, Vol.1, 2003.
- Gretzer M, Partin AW. Emerging Technology presented at the 2003 AUA: Best of the 2003 AUA Annual Meeting.[Meeting Review]. Rev in Urol. 5(3):156-181.
- Gretzer MB and Partin AW. PSA Markers in Prostate Cancer Detection. Urologic Clinics of North America. 30 (2003) 677-686.
- Gretzer, MB, Epstein, J.I, Pound, C.P, Walsh, P.C, and Partin, A.P. Substratificton of Stage T1c Prostate Cancer based on the Probability of Biochemical Failure. Urology 60 (6): 1034-1039. 2002.
- Gretzer, MB, Han, M, Trock, B, and Walsh, PC. A Critical Analysis of Biochemical Failure in Surgically Treated Men using the American Society for therapeutic Radiation and Oncology Criteria. J. Urol. 2003. 168(4). 1419-1422.
- Gretzer MB, Veltri RW, Partin AW, Chan DW: Modern Tumor Marker Discovery in Urology: Surface Enhanced Laser Desorption and Ionization (SELDI). Rev in Urol. 5:81-89, 2003.
|
|
 |
